close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

IQVIA Holdings, Inc. Common Stock (NY:IQV)

220.61 -2.94 (-1.32%)
Official Closing Price Updated: 7:00 PM EST, Nov 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about IQVIA Holdings, Inc. Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
15 16 Next >
News headline image
AI Revolutionizes Cardiovascular Clinical Trials: A Leap Towards Cheaper, Faster Drug Development
San Francisco, CA – November 13, 2025 – Artificial Intelligence (AI) has achieved a pivotal breakthrough in the medical field, successfully adjudicating clinical events in cardiovascular trials. This... 
Via TokenRing AI
Topics Artificial Intelligence
News headline image
3 Inflated Stocks with Warning Signs
The stocks in this article are all trading near their 52-week highs. This strength often reflects positive developments such as new product launches, favorable industry trends, or improved financial... 
Via StockStory
News headline image
3 Cash-Producing Stocks We Approach with Caution
A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand. 
Via StockStory
News headline image
Earnings Scheduled For October 28, 2025 ↗
 
Via Benzinga
News headline image
Nvidia's AI Reign: A $5 Trillion Bellwether Shaping Wall Street's Fortunes
Nvidia's (NASDAQ: NVDA) recent stock performance has been a whirlwind of soaring highs and sharp corrections, acting as a potent barometer for the broader Wall Street landscape as of November 11, 2025.... 
Via MarketMinute
Topics Artificial Intelligence Economy Law Enforcement
News headline image
Q3 Earnings Highs And Lows: IQVIA (NYSE:IQV) Vs The Rest Of The Drug Development Inputs & Services Stocks
As the Q3 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the drug development inputs & services industry, including IQVIA (NYSE:IQV) and its... 
Via StockStory
News headline image
Dr. William G. Kaelin Jr. joins IQVIA Board of Directors
From IQVIA
Via Business Wire
News headline image
Corporate Earnings Fuel Market Gains, But Mixed Results Hint at Underlying Volatility
Recent third-quarter (Q3) 2025 corporate earnings have painted a complex yet largely positive picture for North American equity markets. While robust performances from key sectors, particularly... 
Via MarketMinute
Topics Artificial Intelligence Earnings Economy
News headline image
IQVIA’s Q3 Earnings Call: Our Top 5 Analyst Questions
IQVIA's third quarter results reflected stable operational execution, with revenue and profit slightly ahead of Wall Street expectations. Management identified robust free cash flow generation and a... 
Via StockStory
Topics Earnings
News headline image
Why IQVIA (IQV) Shares Are Trading Lower Today
Shares of clinical research company IQVIA (NYSE: IQV) fell 2.5% in the afternoon session after TD Cowen downgraded its rating on the stock from Buy to Hold. The firm cited valuation concerns as the... 
Via StockStory
News headline image
This Edwards Lifesciences Analyst Turns Bullish; Here Are Top 4 Upgrades For Wednesday ↗
 
Via Benzinga
News headline image
IQV Q3 Deep Dive: Clinical Research Demand and AI Initiatives Drive Steady Growth
Clinical research company IQVIA (NYSE: IQV) reported Q3 CY2025 results topping the market’s revenue expectations, with sales up 5.2% year on year to $4.1 billion. The company expects the full year’s... 
Via StockStory
Topics Artificial Intelligence
News headline image
Nvidia Rockets Towards $5 Trillion Valuation, Reshaping the Global Tech Landscape
As of October 2025, Nvidia (NASDAQ: NVDA) stands on the precipice of a historic $5 trillion market valuation, a testament to its unparalleled dominance in the artificial intelligence (AI) and... 
Via MarketMinute
Topics Artificial Intelligence Economy
News headline image
IQVIA HOLDINGS INC (NYSE:IQV) Reports Q3 2025 Earnings Beat and Positive Market Reaction ↗
IQVIA Q3 2025 earnings beat EPS estimates with $3.00 per share. Revenue grew 5.2% to $4.10B. The company reaffirmed its strong full-year 2025 guidance. 
Via Chartmill
Topics Earnings
News headline image
IQVIA (NYSE:IQV) Beats Q3 Sales Expectations
Clinical research company IQVIA (NYSE: IQV) reported revenue ahead of Wall Street’s expectations in Q3 CY2025, with sales up 5.2% year on year to $4.1 billion. The company expects the full year’s... 
Via StockStory
News headline image
Nasdaq 100 Hits 26,000, Gold Falls Below $4,000: What's Moving Markets Tuesday? ↗
Tech stocks hit new highs as the Nasdaq 100 rallies 0.7% midday. Investors eye a Fed rate cut, Trump-Xi meeting, and major tech earnings. 
Via Benzinga
Topics Economy
News headline image
IQVIA Reports Third-Quarter 2025 Results
From IQVIA Holdings Inc.
Via Business Wire
News headline image
IQVIA (IQV) Reports Earnings Tomorrow: What To Expect
Clinical research company IQVIA (NYSE: IQV) will be reporting earnings this Tuesday morning. Here’s what investors should know. 
Via StockStory
Topics Artificial Intelligence
News headline image
3 Healthcare Stocks Walking a Fine Line
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. But financial performance has lagged recently as players offloaded surplus COVID... 
Via StockStory
Topics Stocks
News headline image
IQVIA CEO Ari Bousbib to Speak at UBS Global Healthcare Conference on November 11, 2025
From IQVIA
Via Business Wire
News headline image
Why IQVIA (IQV) Stock Is Trading Up Today
Shares of clinical research company IQVIA (NYSE: IQV) jumped 3.6% in the afternoon session after Bank of America raised its price target on the company's shares to $230 from $215. The adjustment from... 
Via StockStory
Topics Artificial Intelligence
News headline image
3 Reasons to Sell IQV and 1 Stock to Buy Instead
IQVIA has had an impressive run over the past six months as its shares have beaten the S&P 500 by 11.8%. The stock now trades at $200.20, marking a 39.8% gain. This was partly thanks to its solid... 
Via StockStory
Topics Stocks
News headline image
This Tractor Supply Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday ↗
 
Via Benzinga
News headline image
Looking Into IQVIA Holdings Inc's Recent Short Interest ↗
 
Via Benzinga
News headline image
Market Minute: Fed's Dovish Pivot Amidst Softening Labor Market – What It Means for Investors
The U.S. labor market is flashing clear signs of weakness as of October 2025, prompting a significant shift in the Federal Reserve's monetary policy. With unexpected job losses and a rising... 
Via MarketMinute
Topics Artificial Intelligence Bonds Economy
News headline image
Demystifying IQVIA Hldgs: Insights From 8 Analyst Reviews ↗
 
Via Benzinga
News headline image
Illumina's BioInsight Launch Sparks Optimism, Signals New Era for Genomic Data and AI
San Diego, CA – October 1, 2025 – Illumina, Inc. (NASDAQ: ILMN) saw its shares surge by 6.6% today following the announcement and immediate launch of its new business unit, BioInsight. This strategic... 
Via MarketMinute
Topics Artificial Intelligence Intellectual Property
News headline image
Trump-Pfizer Deal Pushes Health Care Stocks To Best Rally In 5 Years ↗
Health care stocks rallied after Trump struck a drug pricing deal with Pfizer, offering major discounts and pausing pharma tariffs. 
Via Benzinga
Topics Government
News headline image
Why IQVIA (IQV) Stock Is Trading Up Today
Shares of clinical research company IQVIA (NYSE: IQV) jumped 6.3% in the afternoon session after the company, in partnership with GSK, announced a major update to its Vaccine Track data tool for... 
Via StockStory
Topics Government
News headline image
Healthcare Sector Navigates Turbulent Waters as Drug Pricing Agreements Reshape Market Landscape
September 30, 2025 – The healthcare sector today finds itself at a pivotal juncture, experiencing a complex mix of optimism and apprehension. While a landmark drug-pricing agreement between... 
Via MarketMinute
Topics Artificial Intelligence Economy Government
< Previous 1 2 3 4 5 6 7 8 9
...
15 16 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at $3.75/week.

Subscribe Today